Alternative Data Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to alternative data market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Alternative Data Market News

  • In April 2023, New data fields of employee lifecycle stages were launched by Thinknum Alternative Data to its employee sentiment datasets enabling people analytics teams and investors to use this as a proxy for an 'employee NPS' while also helping top-rated employers set interviews through employee referrals.
  • In September 2022, Thinknum Alternative Data unveiled plans to merge data Similarweb, SensorTower, Thinknum, Caplight and Pathmatics with Lagoon a robust infrastructure offering an alternative data source for investment research, due diligence, deal sourcing/origination and post-acquisition strategies in private markets.
  • In May 2022, M Science LLC launched a consumer spending trends platform with daily, weekly, monthly and semi-annual visibility into consumer behavior and competitive benchmarking. This enabled real-time analysis of what was happening with consumer spending trends and an unmatched performance breakdown for Australian brands through a consumer spending platform.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Alternative Data Market size was valued at USD 10.18 Billion in 2023 and is poised to grow from USD 14.79 Billion in 2025 to USD 292.59 Billion by 2032, growing at a CAGR of 45.23 % in the forecast period (2025-2032).

'1010Data', 'Advan', 'Dataminr', 'Earnest Research', 'M Science', 'Preqin', 'RavenPack', 'Thinknum Alternative Data', 'UBS Evidence Lab', 'YipitData ', 'Beijing Tendcloud Tianxia Technology ', 'Convergence ', 'Geotab Inc.', 'Intrinio ', 'Japan Exchange Group '

Growing Application of Alternate Data in Hedge Funds

Implementation of Technology to Handle Large Volume Data: Bioinformatics tools allow the identification of new biomarkers based on changes in human physiology highlighted by Alternative Data results. Biomarkers have utility for in-vitro diagnostics, environmental toxicology screening and drug discovery and development platform methods. Over the past decade, the omics revolution has amplified Alternative Data usages in biomedical fields.

North America is dominating the market due to increasing adoption of alternative data, resulting in the expansion of alternative data market size. The sizeable market share of the region is attributed to a number of market players such as Advan, Eagle Alpha, M Science and UBS Evidence Lab. This factor along with the early adoption of alternative data from range of industry verticals makes this nation most prominent holder in market. Today, over 70% of American asset managers want to include alternative data in their investment strategy. Business alliances and purchases from Nasdaq and S&P Global Platts will also help spur the growth of the regional market. These are raising it above otherwise competitive regions.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Alternative Data Market
Alternative Data Market

Report ID: SQMIG45C2095

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE